Developing nanoparticles to deliver HIV-1 vaccines
Official title: Nanoparticle-based development for HIV-1 biomolecule delivery
Funded at International AIDS Vaccine Initiative · NIH-10863796 · Data updated 2026-11-12
This study is working on tiny particles that can help deliver better vaccines for HIV, aiming to create safer and more effective options to help prevent HIV infection for people at risk.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | International AIDS Vaccine Initiative NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 15, 2021 |
| Project end | July 31, 2026 |
| Funding year | 2023 |
| Award (this year) | $635,012 |
| NIH project number | 272201600011I-P00003-759302100239-1 |
| Project ID | NIH-10863796 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at high risk for HIV infection or those interested in participating in HIV vaccine trials.
✕Less likely to help
Patients who are already living with HIV or those who are not at risk for HIV infection may not benefit from this research.
What this research studies
This research focuses on creating nanoparticles that can effectively deliver biomolecules for HIV-1 vaccine development. By utilizing advanced techniques in chemistry and molecular biology, the project aims to enhance the delivery and efficacy of potential vaccines against HIV. The approach includes process development and analytical characterization to ensure that the vaccines can progress through clinical trials safely and effectively. Patients may benefit from improved vaccine options that could lead to better prevention of HIV infection.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines that significantly reduce the risk of HIV infection.
How similar studies have gone: Other research has shown promise in using nanoparticle delivery systems for vaccines, indicating a potential for success in this novel approach.
Where this research is happening
-
International AIDS Vaccine Initiative
New York, United States Active
Researchers
- Principal investigator: Hassell, Thomas — International AIDS Vaccine Initiative
- Study coordinator: Hassell, Thomas
Related research
Other NIH-funded projects on the same topics.
-
Creating vaccines for influenza and other infectious diseases
This study is all about creating new vaccines to help protect people from the flu and other infections, so patients can look forward to better options for staying healthy.
-
Developing vaccines and biologics for infectious diseases
This study is working on creating and improving vaccines to help protect people from infectious diseases like the flu and Nipah virus, so that patients can have better options for staying healthy.
-
Creating vaccines for human trials against influenza and other infectious diseases
This study is working on creating new vaccines to help protect people from flu and other infectious diseases, including those that could be used in harmful situations, so that everyone can have safer and more effective options to stay healthy.
-
Developing and producing new vaccines for infectious diseases.
This study is all about creating and testing new vaccines to help protect people from infectious diseases, including those that could come from bioterrorism or drug-resistant germs, so that patients can have better options for staying healthy.
-
New mRNA vaccines to prevent tuberculosis for adolescents and adults
A new mRNA vaccine approach aims to prevent TB in teens and adults and reduce transmission, using advanced vaccine technology.
-
New mRNA Vaccines for Tuberculosis
This research explores new mRNA vaccine technology to protect adolescents and adults from tuberculosis, a serious lung infection.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.